Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Cab39 | Rat | (1->4)-beta-D-glucan | multiple interactions | ISO | Cab39 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CAB39 mRNA | CTD | PMID:36331819 | Cab39 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of CAB39 mRNA | CTD | PMID:22298810 | Cab39 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CAB39 mRNA | CTD | PMID:33387578 | Cab39 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CAB39 mRNA | CTD | PMID:34747641 | Cab39 | Rat | 2,4,6-trinitrobenzenesulfonic acid | decreases expression | EXP | | 6480464 | Trinitrobenzenesulfonic Acid results in decreased expression of CAB39 mRNA | CTD | PMID:12163651 | Cab39 | Rat | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2,4-dinitrotoluene affects the expression of CAB39 mRNA | CTD | PMID:21346803 | Cab39 | Rat | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2,6-dinitrotoluene affects the expression of CAB39 mRNA | CTD | PMID:21346803 | Cab39 | Rat | 4,4'-diaminodiphenylmethane | increases expression | ISO | Cab39 (Mus musculus) | 6480464 | 4,4'-diaminodiphenylmethane results in increased expression of CAB39 mRNA | CTD | PMID:18648102 | Cab39 | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | Cab39 (Mus musculus) | 6480464 | bisphenol S results in increased expression of CAB39 mRNA | CTD | PMID:39298647 | Cab39 | Rat | 4,4'-sulfonyldiphenol | multiple interactions | ISO | CAB39 (Homo sapiens) | 6480464 | [bisphenol S co-treated with Fulvestrant] results in increased methylation of CAB39 gene | CTD | PMID:31601247 | Cab39 | Rat | aconitine | decreases expression | EXP | | 6480464 | Aconitine results in decreased expression of CAB39 protein | CTD | PMID:33236894 | Cab39 | Rat | aflatoxin B1 | decreases methylation | ISO | CAB39 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of CAB39 intron | CTD | PMID:30157460 | Cab39 | Rat | all-trans-retinol | decreases expression | EXP | | 6480464 | Vitamin A deficiency results in decreased expression of CAB39 mRNA | CTD | PMID:12163651 | Cab39 | Rat | Aroclor 1254 | decreases expression | ISO | Cab39 (Mus musculus) | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of CAB39 mRNA | CTD | PMID:23650126 | Cab39 | Rat | arsenite(3-) | multiple interactions | ISO | CAB39 (Homo sapiens) | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to CAB39 mRNA] | CTD | PMID:32406909 | Cab39 | Rat | Azoxymethane | multiple interactions | ISO | Cab39 (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CAB39 more ... | CTD | PMID:29950665 | Cab39 | Rat | benzo[a]pyrene | affects methylation | ISO | CAB39 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of CAB39 intron | CTD | PMID:30157460 | Cab39 | Rat | benzo[a]pyrene diol epoxide I | decreases expression | ISO | CAB39 (Homo sapiens) | 6480464 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of CAB39 mRNA | CTD | PMID:19150397 | Cab39 | Rat | benzo[e]pyrene | decreases methylation | ISO | CAB39 (Homo sapiens) | 6480464 | benzo(e)pyrene results in decreased methylation of CAB39 intron | CTD | PMID:30157460 | Cab39 | Rat | beta-lapachone | increases expression | ISO | CAB39 (Homo sapiens) | 6480464 | beta-lapachone results in increased expression of CAB39 mRNA | CTD | PMID:38218311 | Cab39 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of CAB39 mRNA | CTD | PMID:25181051 | Cab39 | Rat | bisphenol A | increases expression | ISO | CAB39 (Homo sapiens) | 6480464 | bisphenol A results in increased expression of CAB39 protein | CTD | PMID:37567409 | Cab39 | Rat | bisphenol A | decreases expression | ISO | CAB39 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of CAB39 protein | CTD | PMID:33376534 | Cab39 | Rat | Brodifacoum | increases expression | EXP | | 6480464 | bromfenacoum results in increased expression of CAB39 protein | CTD | PMID:28903499 | Cab39 | Rat | cadmium atom | multiple interactions | ISO | Cab39 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CAB39 more ... | CTD | PMID:37236586 | Cab39 | Rat | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of CAB39 mRNA | CTD | PMID:33453195 | Cab39 | Rat | cadmium dichloride | multiple interactions | ISO | Cab39 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of CAB39 more ... | CTD | PMID:37236586 | Cab39 | Rat | calcitriol | increases expression | ISO | CAB39 (Homo sapiens) | 6480464 | Calcitriol results in increased expression of CAB39 mRNA | CTD | PMID:16002434 | Cab39 | Rat | camptothecin | decreases expression | ISO | CAB39 (Homo sapiens) | 6480464 | Camptothecin results in decreased expression of CAB39 mRNA | CTD | PMID:17374387 | Cab39 | Rat | carbon nanotube | decreases expression | ISO | Cab39 (Mus musculus) | 6480464 | Nanotubes, Carbon analog results in decreased expression of CAB39 mRNA | CTD | PMID:25554681 | Cab39 | Rat | chlorpyrifos | increases expression | ISO | Cab39 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of CAB39 mRNA | CTD | PMID:37019170 | Cab39 | Rat | clofibrate | decreases expression | ISO | Cab39 (Mus musculus) | 6480464 | Clofibrate results in decreased expression of CAB39 mRNA | CTD | PMID:17585979 | Cab39 | Rat | copper(II) sulfate | increases expression | ISO | CAB39 (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of CAB39 mRNA | CTD | PMID:19549813 | Cab39 | Rat | daunorubicin | decreases expression | ISO | CAB39 (Homo sapiens) | 6480464 | Daunorubicin results in decreased expression of CAB39 mRNA | CTD | PMID:17374387 | Cab39 | Rat | dextran sulfate | multiple interactions | ISO | Cab39 (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CAB39 more ... | CTD | PMID:29950665 | Cab39 | Rat | dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of CAB39 mRNA | CTD | PMID:21266533 | Cab39 | Rat | dicrotophos | decreases expression | ISO | CAB39 (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of CAB39 mRNA | CTD | PMID:28302478 | Cab39 | Rat | dioxygen | affects methylation | ISO | Cab39 (Mus musculus) | 6480464 | Oxygen deficiency affects the methylation of CAB39 promoter | CTD | PMID:24205000 | Cab39 | Rat | dioxygen | increases expression | ISO | Cab39 (Mus musculus) | 6480464 | Oxygen deficiency results in increased expression of CAB39 mRNA | CTD | PMID:24205000 | Cab39 | Rat | doxorubicin | decreases expression | ISO | CAB39 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of CAB39 mRNA | CTD | PMID:29803840 | Cab39 | Rat | ethanol | affects splicing | ISO | Cab39 (Mus musculus) | 6480464 | Ethanol affects the splicing of CAB39 mRNA | CTD | PMID:30319688 | Cab39 | Rat | etoposide | decreases expression | ISO | CAB39 (Homo sapiens) | 6480464 | Etoposide results in decreased expression of CAB39 mRNA | CTD | PMID:17374387 | Cab39 | Rat | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of CAB39 mRNA | CTD | PMID:24136188 | Cab39 | Rat | flutamide | decreases expression | EXP | | 6480464 | Flutamide results in decreased expression of CAB39 mRNA | CTD | PMID:24793618 | Cab39 | Rat | fulvestrant | multiple interactions | ISO | CAB39 (Homo sapiens) | 6480464 | [bisphenol S co-treated with Fulvestrant] results in increased methylation of CAB39 gene | CTD | PMID:31601247 | Cab39 | Rat | geldanamycin | increases expression | ISO | CAB39 (Homo sapiens) | 6480464 | geldanamycin results in increased expression of CAB39 mRNA | CTD | PMID:26705709 | Cab39 | Rat | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of CAB39 mRNA | CTD | PMID:22061828 | Cab39 | Rat | hypochlorous acid | increases expression | ISO | Cab39 (Mus musculus) | 6480464 | Hypochlorous Acid results in increased expression of CAB39 mRNA | CTD | PMID:19376150 | Cab39 | Rat | ivermectin | decreases expression | ISO | CAB39 (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of CAB39 protein | CTD | PMID:32959892 | Cab39 | Rat | methapyrilene | decreases methylation | ISO | CAB39 (Homo sapiens) | 6480464 | Methapyrilene results in decreased methylation of CAB39 intron | CTD | PMID:30157460 | Cab39 | Rat | methyl methanesulfonate | decreases expression | ISO | CAB39 (Homo sapiens) | 6480464 | Methyl Methanesulfonate results in decreased expression of CAB39 mRNA | CTD | PMID:23649840 | Cab39 | Rat | nefazodone | increases expression | EXP | | 6480464 | nefazodone results in increased expression of CAB39 mRNA | CTD | PMID:24136188 | Cab39 | Rat | paracetamol | affects expression | ISO | Cab39 (Mus musculus) | 6480464 | Acetaminophen affects the expression of CAB39 mRNA | CTD | PMID:17562736 | Cab39 | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Cab39 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of CAB39 mRNA | CTD | PMID:36331819 | Cab39 | Rat | resveratrol | multiple interactions | ISO | CAB39 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of CAB39 mRNA | CTD | PMID:23557933 | Cab39 | Rat | rotenone | increases expression | ISO | CAB39 (Homo sapiens) | 6480464 | Rotenone results in increased expression of CAB39 mRNA | CTD | PMID:33512557 | Cab39 | Rat | sodium arsenite | decreases expression | ISO | CAB39 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of CAB39 protein | CTD | PMID:38228842 | Cab39 | Rat | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of CAB39 mRNA | CTD | PMID:31150632 | Cab39 | Rat | tetrachloromethane | increases expression | ISO | Cab39 (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of CAB39 mRNA | CTD | PMID:31919559 | Cab39 | Rat | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of CAB39 mRNA | CTD | PMID:23411599|PMID:34492290 | Cab39 | Rat | thiram | increases expression | ISO | CAB39 (Homo sapiens) | 6480464 | Thiram results in increased expression of CAB39 mRNA | CTD | PMID:38568856 | Cab39 | Rat | titanium dioxide | multiple interactions | ISO | Cab39 (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of CAB39 more ... | CTD | PMID:29950665 | Cab39 | Rat | titanium dioxide | decreases methylation | ISO | Cab39 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of CAB39 gene | CTD | PMID:35295148 | Cab39 | Rat | trichloroethene | increases methylation | EXP | | 6480464 | Trichloroethylene results in increased methylation of CAB39 gene | CTD | PMID:27618143 | Cab39 | Rat | triptonide | increases expression | ISO | Cab39 (Mus musculus) | 6480464 | triptonide results in increased expression of CAB39 mRNA | CTD | PMID:33045310 | Cab39 | Rat | vitamin E | increases expression | ISO | CAB39 (Homo sapiens) | 6480464 | Vitamin E results in increased expression of MO25 mRNA | CTD | PMID:19244175 | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||






















